Donor countries, including the UK, and pharmaceutical companies have announced a new plan to tackle killer tropical diseases, which they say have long been neglected by the international community. These include visceral leishmaniasis (kala azar), sleeping sickness and Chagas disease, which have high mortality rates. Read on